SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 203 filers reported holding SEATTLE GENETICS INC in Q1 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $16,668,000 | -0.9% | 265,164 | -16.8% | 0.14% | +3.8% |
| Q4 2016 | $16,820,000 | -1.5% | 318,740 | +0.8% | 0.13% | 0.0% |
| Q3 2016 | $17,082,000 | -2.2% | 316,277 | -26.8% | 0.13% | -3.7% |
| Q2 2016 | $17,464,000 | -37.2% | 432,164 | -45.5% | 0.14% | -27.0% |
| Q1 2016 | $27,812,000 | -42.4% | 792,602 | -26.4% | 0.18% | -39.7% |
| Q4 2015 | $48,302,000 | +16.3% | 1,076,252 | -0.1% | 0.31% | +17.6% |
| Q3 2015 | $41,534,000 | +65.0% | 1,077,121 | +107.1% | 0.26% | +80.0% |
| Q2 2015 | $25,167,000 | +37.1% | 519,983 | +0.1% | 0.14% | +42.2% |
| Q1 2015 | $18,360,000 | -35.4% | 519,376 | -19.9% | 0.10% | -11.3% |
| Q3 2013 | $28,414,000 | +20.1% | 648,287 | -13.8% | 0.12% | +6.5% |
| Q2 2013 | $23,655,000 | – | 751,920 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |